PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy
Diabetes · 2024
DOI: 10.2337/db24-0240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Xinyi Chen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, U.K. Hauptthemen laut MEDLINE: Sterol Regulatory Element Binding Protein 1, Obesity, Myocytes, Cardiac, Cardiomyopathies. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: British Heart Foundation, NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Obesity-induced lipid overload in cardiomyocytes contributes to profound oxidative stress and cardiomyopathy, culminating in heart failure. In this study, we investigate a novel mechanism whereby lipids accumulate in cardiomyocytes, and seek the relevant treatment strategies. P21-activated kinase 3 (PAK3) was elevated in obese human myocardium, and the murine hearts and cardiomyocytes upon diet- or fatty acid–induced stress, respectively. Mice with cardiac-specific overexpression of PAK3 were more susceptible to the development of cardiac dysfunction upon diet stress, at least partially, because of increased deposition of toxic lipids within the myocardium. Mechanistically, PAK3 promoted the nuclear expression of sterol regulatory element binding protein 1c (SREBP1c) through activation of mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase β-1 (S6K1) pathway in cardiomyocytes, resulting in abnormal lipid genes profile, accumulation of excessive lipids, and oxidative stress. More importantly, PAK3 knockdown attenuated fatty acid–induced lipotoxicity and cell death in rat and human cardiomyocytes. More importantly, the S6K1 or SREBP1c inhibitor alleviated PAK3-triggered intracellular lipid overload and cardiac dysfunction under obese stress. Collectively, we have demonstrated that PAK3 impairs myocardial lipid homeostasis, while inhibition of cardiac lipotoxicity mitigates cardiac dysfunction. Our study provides a promising therapeutic strategy for ameliorating obesity cardiomyopathy. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, U.K.
- Department of Internal Medicine III, University of Kiel, Kiel, Germany.
- DZHK, Partner Site Hamburg/Kiel/Lübeck, German Centre for Cardiovascular Research, Kiel, Germany.
- Surgery Department, Baylor College of Medicine, Houston, TX.
- Institute of Molecular Cardiology, University of Louisville, Louisville, KY.
- Diabetes, Endocrinology and Metabolism Centre, National Institute for Health and Care Research Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University Hospitals National H…
ORCID-Profile: Wei Liu
Förderung
- British Heart Foundation
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Chen, X., Ruiz-Velasco, A., Zou, Z., Hille, S. S., Ross, C., Fonseka, O., Gare, S. R., Alatawi, N. H. O., Raja, R., Zhang, J., Kaur, N., Zhao, X., Morrell-Davies, H., Miller, J. M., Abouleisa, R. R. E., Ou, Q., Frank, D., Rutter, M. K., Pinali, C., …, & Liu, W. (2024). PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. Diabetes. https://doi.org/10.2337/db24-0240
Vancouver
Chen X, Ruiz-Velasco A, Zou Z, Hille SS, Ross C, Fonseka O, et al. PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. Diabetes. 2024. doi:10.2337/db24-0240
BibTeX
@article{Chen2024,
author = {Chen, Xinyi and Ruiz-Velasco, Andrea and Zou, Zhiyong and Hille, Susanne S and Ross, Claire and Fonseka, Oveena and Gare, Sanskruti R and Alatawi, Nasser Hawimel O and Raja, Rida and Zhang, Jiayan and Kaur, Namrita and Zhao, Xiangjun and Morrell-Davies, Henrietta and Miller, Jessica M and Abouleisa, Riham R E and Ou, Qinghui and Frank, Derk and Rutter, Martin K and Pinali, Christian and Wang, Tao and Mohamed, Tamer M A and Müller, Oliver J and Liu, Wei},
title = {PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db24-0240}
}
EUVIMED